 |
| Bovine Mastitis Market |
The global bovine mastitis market is estimated to be valued at US$ 1497.52 Mn in 2023 and is expected
to exhibit a CAGR of 5.2% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Overview:
Bovine mastitis refers to the inflammation of mammary glands in dairy cows. It
leads to physical, chemical and usually bacteriological changes in the milk and
udder tissue. It is one of the costliest diseases affecting the dairy industry
worldwide. Symptoms of bovine mastitis include hard and warm udder, abnormal
appearance of milk such as flaky clots or watery secretion, and decreased milk
production. Bovine mastitis is primarily caused by bacterial infections
including Staphylococcus aureus, Streptococcus, and E.coli. With economic
developments, there is rising demand for milk and other dairy products across
the globe which is driving growth of the bovine mastitis market.
Market key trends:
One of the key trends in the bovine mastitis market is increasing adoption of
advanced diagnostic testing. Traditionally, mastitis was diagnosed through
visual observation of the udder and milk quality. However, advanced diagnostic
technologies allow accurate, early and on-farm diagnosis. Advanced tests
include California mastitis test, Surf field mastitis test, Cowside test, and
advanced DNA-based methods. These help detect both clinical and subclinical
mastitis, and identify the specific causative bacteria or pathogen, allowing
targeted treatment. Rapid diagnosis helps curtail economic losses and treatment
becomes more effective.
Porter’s Analysis
Threat of new entrants: The Bovine
Mastitis Market has moderate threat of new entrants due to established
distribution channels and high R&D costs.
Bargaining power of buyers: Buyers have moderate bargaining power due to
availability of generic alternatives and competition in the market.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power
as there are many suppliers in the market and switching costs are low.
Threat of new substitutes: Threat of substitutes is low as there are limited
treatment alternatives for bovine mastitis.
Competitive rivalry: The bovine mastitis market experiences high competitive
rivalry between major manufacturers.
Key Takeaways
The global bovine mastitis market is expected to witness high growth,
exhibiting CAGR of 5.2% over the
forecast period, due to increasing dairy production and growing animal
healthcare expenditure.
Regional analysis: North America dominates the global bovine mastitis market
due to stringent food safety regulations and developed animal healthcare
infrastructure in the region. Asia Pacific is expected to witness fastest
growth over the forecast period owing to rising dairy consumption, growing
awareness regarding bovine diseases, and expansion of key players in emerging countries.
Key players: Key players operating in the bovine mastitis market are Zoetis,
Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG,
Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation,
Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd. Zoetis
dominates the global market due to its diverse product portfolio and strong
distribution network across major markets.
Read More: https://www.ukwebwire.com/bovine-mastitis-market-analysis-and-trends/